She got three Moderna covid vaccine priors to getting covid; diagnosis of central centrifugal and cicatricial alopecia; hair was falling out/shedding; dandruff; itching all over her head; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (She got three Moderna covid vaccine priors to getting covid), ALOPECIA SCARRING (diagnosis of central centrifugal and cicatricial alopecia), ALOPECIA (hair was falling out/shedding), DANDRUFF (dandruff) and PRURITUS (itching all over her head) in a 47-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.    Co-suspect product included non-company product NIRMATRELVIR, RITONAVIR (PAXLOVID) for COVID-19.    The patient's past medical history included Back surgery (Back surgery about 4 years ago). Concurrent medical conditions included Allergy. Concomitant products included OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) for Allergy.   In September 2022, the patient started NIRMATRELVIR, RITONAVIR (PAXLOVID) (unknown route) at an unspecified dose. On an unknown date, the patient received third dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (She got three Moderna covid vaccine priors to getting covid), ALOPECIA SCARRING (diagnosis of central centrifugal and cicatricial alopecia), ALOPECIA (hair was falling out/shedding), DANDRUFF (dandruff) and PRURITUS (itching all over her head). At the time of the report, COVID-19 (She got three Moderna covid vaccine priors to getting covid), DANDRUFF (dandruff) and PRURITUS (itching all over her head) outcome was unknown and ALOPECIA SCARRING (diagnosis of central centrifugal and cicatricial alopecia) and ALOPECIA (hair was falling out/shedding) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Biopsy: diagnosis of central centrifugal and cicatricial alopecia. On an unknown date, Blood iron: fine. On an unknown date, SARS-CoV-2 test: Positive. On an unknown date, Vitamin D: fine.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   Claritin she was taking this at the time her hair was falling out, takes when her allergies were flaring up. Allergy Drops (unknown name) will likely have to start using again in the summer.  The left and right sides of patient's head was normal but cannot put a comb through the back of her head since her hair was falling out. She does not have a bald spot, but she was shedding. This all occurred the same week she was taking Paxlovid.  Patient saw online, on private groups on social media for hair loss, saw that there were people that had the same symptoms as her from taking Paxlovid and from having the Pfizer Covid vaccine.   Patient knows her body. Her hair was still past her shoulders, even though she has 6 inches cut off. When she blows dries it or combs and noticed she could see through it and all on her arm. Still as of right now from the back part where her hair comes down on her shoulders, it was eaten up, it was fragile and wavy. She went to the doctor yesterday.   About two months ago was when she received the central centrifugal and cicatricial alopecia diagnosis. Doctors are always saying that it was the vitamin D levels and iron, but her Vitamin D levels, and iron was fine. When she looked up Alopecia, it was all big bald spots which she does not have. She has so much new growth, it was insane. Has not had a perm since August. She never had a wig or glue, always had long pretty hair. She only had to flat iron her hair once a week. She finished Paxlovid and this was the only medication she has finished aside from after she had back surgery. There are literally over a dozen social media groups where people's hair was coming out since taking Paxlovid.   No treatment drug specified or reported for hair loss related event.   This case was linked to US-MODERNATX, INC.-MOD-2023-723078 (Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 08-May-2023: Live follow-up: QE number updated. Sender's Comments:  US-MODERNATX, INC.-MOD-2023-723078: Monovalent Case